Sareum Holdings
OverviewSuggest Edit
Sareum Holdings discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases. The Company's drug development programmes aim to improve outcomes for patients with serious medical conditions and where current therapies are inadequate. Sareum Holdings develops therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The Company’s product pipeline includes Checkpoint Kinase 1, Aurora+FLT3 kinase, TYK2 kinase-autoimmune diseases and TYK2 kinase-cancer.
| Type | Public | |
| Founded | 2003 | |
| HQ | Pampisford, GB | Map |
| Website | sareum.com |
Key People/Management at Sareum Holdings
Stephen Parker Dphil
John Reader
Clive Birch
Sareum Holdings Office Locations
Sareum Holdings Financials and Metrics
Sareum Holdings Revenue
| GBP | |
|---|---|
Revenue (FY, 2007) | 2.5m |
Gross profit (FY, 2007) | 618.1k |
Gross profit margin (FY, 2007), % | 25% |
Net income (FY, 2007) | (527.4k) |
EBIT (FY, 2007) | (734.6k) |
Market capitalization (7-Apr-2021) | 60.5m |
Closing stock price (7-Apr-2021) | 0.0 |
Cash (30-Jun-2019) | 919.0k |
EV | 59.5m |
| GBP | FY, 2007 |
|---|---|
Revenue | 2.5m |
Cost of goods sold | 1.9m |
Gross profit | 618.1k |
Gross profit Margin, % | 25% |
| GBP | FY, 2007 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
|---|---|---|---|---|---|---|---|
Cash | 660.3k | 700.6k | 1.5m | 1.3m | 2.3m | 1.4m | 919.0k |
Accounts Receivable | 472.4k | ||||||
Current Assets | 1.5m | 1.1m | 1.7m | 1.5m | 2.4m | 1.8m | 1.2m |
| GBP | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|---|---|
Cash From Operating Activities | (785.3k) | (644.2k) | (678.0k) | 843.9k | (1.6m) |
Cash From Investing Activities | (970.8k) | 67.6k | (592.7k) | 216.0k | 3.7k |
Cash From Financing Activities | 2.0m | 1.4m | 1.0m | (6.9k) | 658.3k |
Net Change in Cash | 279.0k | 779.4k | (227.4k) | 1.1m | (930.2k) |
Sareum Holdings Cybersecurity Score
Sareum Holdings Online and Social Media Presence
1.26k Twitter followers
Sareum Holdings has 1.26k Twitter Followers. The number of followers has increased 0.3% month over month and increased 1.1% quarter over quarter
Sareum Holdings's Trends
Twitter Engagement Stats for @Sareumplc
409
Tweets
430
Following
1.3k
Followers
1
Tweets last 30 days
0
Avg. likes per Tweet
100%
Tweets with engagement
Sareum Holdings Blogs
Sareum Notes New UK Government Covid-19 Initiative
Sareum to Present at the LSX World Congress 2021
Sareum to Participate in the Edison Open House
Update re: FLT3+Aurora Kinase Inhibitor Programme
US Patent Grant for TYK2/JAK1 Anticancer Candidate
Nature Article Highlights Role of TYK2 in Covid-19
Sareum Holdings Frequently Asked Questions
When was Sareum Holdings founded?
Sareum Holdings was founded in 2003.
Who are Sareum Holdings key executives?
Sareum Holdings's key executives are Stephen Parker Dphil, John Reader and Clive Birch.
How many employees does Sareum Holdings have?
Sareum Holdings has 6 employees.
What is Sareum Holdings revenue?
Latest Sareum Holdings annual revenue is £2.5 m.
What is Sareum Holdings revenue per employee?
Latest Sareum Holdings revenue per employee is £411.8 k.
Who are Sareum Holdings competitors?
Competitors of Sareum Holdings include Xilio Therapeutics, Karo Pharma and Luye Pharma.
Where is Sareum Holdings headquarters?
Sareum Holdings headquarters is located at 2a Langford Arch London Rd, Pampisford.
Where are Sareum Holdings offices?
Sareum Holdings has an office in Pampisford.
How many offices does Sareum Holdings have?
Sareum Holdings has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies